Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
Công thức hóa học
C11H12Cl2N2O5
Monoisotopic mass
322.012326918
InChI
InChI=1S/C11H12Cl2N2O5/c12-10(13)11(18)14-8(5-16)9(17)6-1-3-7(4-2-6)15(19)20/h1-4,8-10,16-17H,5H2,(H,14,18)/t8-,9-/m1/s1
InChI Key
InChIKey=WIIZWVCIJKGZOK-RKDXNWHRSA-N
IUPAC Name
2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide
Traditional IUPAC Name
chloramphenicol
SMILES
OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O
Độ hòa tan
2500 mg/L (at 25 °C)
pKa (strongest acidic)
7.49
pKa (Strongest Basic)
-2.8
Refractivity
73.2 m3·mol-1
Dược Lực Học :
Chloramphenicol is a broad-spectrum antibiotic that was derived from the bacterium Streptomyces venezuelae and is now produced synthetically. Chloramphenicol is effective against a wide variety of microorganisms, but due to serious side-effects (e.g., damage to the bone marrow, including aplastic anemia) in humans, it is usually reserved for the treatment of serious and life-threatening infections (e.g., typhoid fever). Chloramphenicol is bacteriostatic but may be bactericidal in high concentrations or when used against highly susceptible organisms. Chloramphenicol stops bacterial growth by binding to the bacterial ribosome (blocking peptidyl transferase) and inhibiting protein synthesis.
Cơ Chế Tác Dụng :
An antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. (From Martindale, The Extra Pharmacopoeia, 29th ed, p106)
Chloramphenicol is lipid-soluble, allowing it to diffuse through the bacterial cell membrane. It then reversibly binds to the L16 protein of the 50S subunit of bacterial ribosomes, where transfer of amino acids to growing peptide chains is prevented (perhaps by suppression of peptidyl transferase activity), thus inhibiting peptide bond formation and subsequent protein synthesis.
Dược Động Học :
▧ Absorption :
Rapidly and completely absorbed from gastrointestinal tract following oral administration (bioavailability 80%). Well absorbed following intramuscular administration (bioavailability 70%). Intraocular and some systemic absorption also occurs after topical application to the eye.
▧ Protein binding :
Plasma protein binding is 50-60% in adults and 32% is premature neonates.
▧ Metabolism :
Hepatic, with 90% conjugated to inactive glucuronide.
▧ Half Life :
Half-life in adults with normal hepatic and renal function is 1.5 - 3.5 hours. In patients with impaired renal function half-life is 3 - 4 hours. In patients with severely impaired hepatic function half-life is 4.6 - 11.6 hours. Half-life in children 1 month to 16 years old is 3 - 6.5 hours, while half-life in infants 1 to 2 days old is 24 hours or longer and is highly variable, especially in low birth-weight infants.
Độc Tính :
Oral, mouse: LD50 = 1500 mg/kg; Oral, rat: LD50 = 2500 mg/kg. Toxic reactions including fatalities have occurred in the premature and newborn; the signs and symptoms associated with these reactions have been referred to as the gray syndrome. Symptoms include (in order of appearance) abdominal distension with or without emesis, progressive pallid cyanosis, vasomotor collapse frequently accompanied by irregular respiration, and death within a few hours of onset of these symptoms.
Chỉ Định :
Used in treatment of cholera, as it destroys the vibrios and decreases the diarrhea. It is effective against tetracycline-resistant vibrios. It is also used in eye drops or ointment to treat bacterial conjunctivitis.
Tương Tác Thuốc :
-
Acetohexamide
Chloramphenicol may increase the effect of sulfonylurea, acetohexamide.
-
Butalbital
Barbiturates such as butalbital may increase the metabolism of Chloramphenicol. Chloramphenicol may decrease the metabolism of Barbiturates. Monitor for decreased serum concentrations/therapeutic effects of chloramphenicol if a barbiturate is initiated/dose increased, or increased effects if a barbiturate is discontinued/dose decreased. In addition, monitor for increased effects of barbiturates if chloramphenicol is initiated/dose increased, or decreased effects if chloramphenicol is discontinued/dose decreased.
-
Chlorpropamide
Chloramphenicol may increase the effect of sulfonylurea, chlorpropamide.
-
Cyclosporine
Chloramphenicol may increase the effect of cyclosporine.
-
Ethotoin
Increases phenytoin, modifies chloramphenicol
-
Fosphenytoin
Increases phenytoin, modifies chloramphenicol
-
Gliclazide
Chloramphenicol may increase the effect of sulfonylurea, gliclazide.
-
Glipizide
Chloramphenicol may increase the effect of sulfonylurea, glipizide.
-
Glisoxepide
Chloramphenicol may increase the effect of sulfonylurea, glisoxepide.
-
Glyburide
Chloramphenicol may increase the effect of sulfonylurea, glibenclamide.
-
Glycodiazine
Chloramphenicol may increase the effect of sulfonylurea, glycodiazine.
-
Lurasidone
Concomitant therapy with a strong CYP3A4 inhibitor will increase level or effect of lurasidone. Coadministration with lurasidone is contraindicated.
-
Mephenytoin
Increases phenytoin, modifies chloramphenicol
-
Phenytoin
Increases phenytoin, modifies chloramphenicol
-
Rifampicin
Rifampin decreases the effect of chloramphenicol
-
Silodosin
Chloramphenicol is a strong inhibitor of CYP3A4 may increase the serum concentration of silodosin by decreasing its metabolism thus increases the potential for adverse side effects. Combination therapy is contraindicated.
-
Tacrolimus
Chloramphenicol may increase the blood concentration of Tacrolimus. Monitor for changes in the therapeutic/toxic effects of Tacrolimus if Chloramphenicol therapy is initiated, discontinued or altered.
-
Thiopental
Chloramphenicol may increase the serum concentration of Thiopental by decreasing Thiopental metabolism. Thiopental may decrease the serum concentration of Chloramphenicol by increasing Chloramphenicol metabolism. Monitor for changes in therapeutic effects of both agents if concomitant therapy is initiated, discontinued or doses are adjusted.
-
Tolazamide
Chloramphenicol may increase the effect of sulfonylurea, tolazamide.
-
Tolbutamide
Chloramphenicol may increase the effect of sulfonylurea, tolbutamide.
Liều Lượng & Cách Dùng :
Liquid - Ophthalmic
Ointment - Ophthalmic
Powder, for solution - Intramuscular
Solution - Ophthalmic
Solution / drops - Ophthalmic
Dữ Kiện Thương Mại
Nhà Sản Xuất
-
Sản phẩm biệt dược : Brochlor
-
Sản phẩm biệt dược : Chloramex
-
Sản phẩm biệt dược : Chlorocid
-
Sản phẩm biệt dược : Chlorocol
-
Sản phẩm biệt dược : Chloromycetin
-
Sản phẩm biệt dược : Chlorsig
-
Sản phẩm biệt dược : Fenicol
-
Sản phẩm biệt dược : Globenicol
-
Sản phẩm biệt dược : Halomycetin
-
Sản phẩm biệt dược : Oleomycetin
-
Sản phẩm biệt dược : Sificetina
Tài Liệu Tham Khảo Thêm
National Drug Code Directory